SMTL ID : 9bg0.1 (1 other biounit)

Tri-complex of Daraxonrasib (RMC-6236), NRAS WT, and CypA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)

GNP.1: 25 residues within 4Å: Chain A: A.12, G.13, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, E.32, Y.33, P.35, T.36, A.60, G.61, N.117, K.118, D.120, L.121, S.146, A.147, K.148 Ligands: MG.2 26 PLIP interactions: 26 interactions with chain A Hydrogen bonds: A:G.14, A:V.15, A:G.16, A:K.17, A:K.17, A:K.17, A:S.18, A:A.19, A:V.30, A:Y.33, A:T.36, A:G.61, A:N.117, A:K.118, A:K.118, A:A.147, A:K.148 Water bridges: A:S.18, A:S.18, A:D.31, A:D.34, A:Q.62, A:Q.62 Salt bridges: A:D.120 pi-Stacking: A:F.29, A:F.29

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: S.18, T.36 Ligands: GNP.1 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:S.18, A:T.36, H2O.1, H2O.2

1 x 01: (1R,2S)-N-[(1P,7S,9S,13R,20M)-21-ethyl-20-{2-[(1R)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide

01.3: 21 residues within 4Å: Chain A: P.35, T.36, I.37, A.60, Q.62, Y.65, M.68 Chain B: R.56, I.58, F.61, M.62, Q.64, G.73, A.102, N.103, Q.112, F.114, W.122, L.123, H.127, R.149 24 PLIP interactions: 15 interactions with chain B, 9 interactions with chain A Hydrophobic interactions: B:I.58, B:I.58, B:F.61, B:F.61, B:F.114, B:L.123, A:P.35, A:I.37, A:A.60, A:Y.65, A:Y.65, A:Y.65, A:M.68 Hydrogen bonds: B:R.56, B:R.56, B:Q.64, B:Q.64, B:N.103, B:N.103 Water bridges: B:R.149 Salt bridges: B:R.56 pi-Cation interactions: B:R.56 pi-Stacking: A:Y.65, A:Y.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cregg, J. et al., Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers. J.Med.Chem. (2025)

Release Date

2025-03-19

Peptides

GTPase NRas: A
Peptidyl-prolyl cis-trans isomerase A: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

GTPase NRas

Peptidyl-prolyl cis-trans isomerase A

Related Entries With Identical Sequence